Seeing Is Believing
CAPR is currently covered by 2 analysts with an average price target of $55.4. This is a potential upside of $36.95 (200.27%) from yesterday's end of day stock price of $18.45.
Capricor Therapeutics's activity chart (see below) currently has 11 price targets and 21 ratings on display. The stock rating distribution of CAPR is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 65% with an average time for these price targets to be met of 892 days.
Highest price target for CAPR is $77, Lowest price target is $25, average price target is $55.4.
Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 11-Oct-2024. First documented stock forecast 15-Sep-2017.
Currently out of the existing stock ratings of CAPR, 11 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$77
$57.55 (295.89%)
$40
25 days ago
(11-Oct-2024)
6/12 (50%)
$59.23 (333.31%)
956
Buy
$25
$5.55 (28.53%)
$12
1 months 11 days ago
(25-Sep-2024)
4/5 (80%)
$14.66 (141.78%)
828
What is CAPR (Capricor Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CAPR (Capricor Therapeutics) with a proven track record?
Which analyst has the current lower performing score on CAPR (Capricor Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CAPR (Capricor Therapeutics)?
Which analyst is the currently most bullish on CAPR (Capricor Therapeutics)?
Which analyst is the currently most reserved on CAPR (Capricor Therapeutics)?